Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Detection of occult Scedosporium species in respiratory tract specimens in cystic fibrosis (CF) by use of selective media

Respiratory samples from cystic fibrosis outpatients were cultured on Sabouraud's dextrose agar (SABD) containing antibiotics, Mycosel, and Scedosporium-sel...

Research

The recruitment and retention of Speech and Language Therapists: What do university students find important?

The increasing need for speech and language therapy (SLT) services, coupled with poor employment retention rates, poses serious cost-benefit considerations.

News & Events

New funding to accelerate AI personalised phage therapies

Wal-yan researchers have been awarded $500,000 for their innovative research, supported by the Western Australian Government’s Future Health Medical Research and Innovation (FHRI) Fund.

News & Events

3rd European Rett Syndrome Conference, October 17-19, Maastricht, The Netherlands

Following last year's World Rett Syndrome Congress held in New Orleans, the 3rd European Rett Syndrome Conference was held in the Netherlands over 3 days.

AusVaxSafety (previously FAST)

The aim of the study is the early identification of problems with the current flu vaccines, and providing parents and professionals with up to date information.

ORIGINS Vision Study

This study is aiming to investigate how sun exposure and time outside impacts the health of your child’s eye and eye growth, over a period of rapid growth in their lives.

News & Events

Researcher Spotlight - Jeff Cannon

Dr Jeffrey Cannon is a Health Economist at The Kids Research Institute Australia. Jeff completed his PhD in health economics at the University of Western Australia. His work in health and medical research spans across maternal and newborn health, infectious diseases and more recently, childhood onset diabetes.

News & Events

CGM with remote monitoring makes for happy families

Parents of young children with type 1 diabetes experience significantly better quality of life and reduced fear of hypoglycaemic episodes when given remote access to their child's continuous glucose monitoring, new Children's Diabetes Centre research has found.